Insider Shareholders with Direct Ownership of Regenxbio Inc. (RGNX)
This section provides a comprehensive overview of the insiders with direct ownership of Regenxbio Inc. (RGNX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
REGENXBIO Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 498,952 | 294,601 | 444,351 $3.75 Million | 55 |
Aug 08, 2024
Added 7.56%
|
|
|
Curran Simpson
Chief Executive Officer |
304,774 | 51,690 | 257,032 $2.17 Million | 18 |
Jan 02, 2025
Added 27.79%
|
|
Vittal Vasista
Chief Financial Officer |
178,441 | 126,931 | 246,534 $2.08 Million | 25 |
Mar 19, 2024
Added 7.52%
|
|
Olivier Danos
Chief Scientific Officer |
249,619 | 24,319 | 231,800 $1.95 Million | 17 |
Jan 02, 2025
Added 20.38%
|
|
Steve Pakola
Chief Medical Officer |
278,096 | 62,116 | 215,980 $1.82 Million | 14 |
Jan 02, 2025
Added 22.94%
|
|
Patrick J. Christmas
Chief Legal Officer |
218,202 | 59,964 | 160,810 $1.36 Million | 21 |
Jan 02, 2025
Reduced 6.62%
|
|
Mitchell Chan
Chief Financial Officer |
58,869 | 0 | 58,869 $496,265 | 1 |
Sep 16, 2024
Added 50.0%
|
| 14,296 | 0 | 14,296 $120,515 | 3 |
May 31, 2024
Added 25.1%
|
|
| 11,286 | 0 | 11,286 $95,140 | 3 |
May 31, 2024
Added 29.8%
|
|
| 62,386 | 51,100 | 11,286 $95,140 | 13 |
Oct 01, 2024
Reduced 46.98%
|
|
| 11,286 | 0 | 11,286 $95,140 | 3 |
May 31, 2024
Added 29.8%
|
|
| 11,286 | 0 | 11,286 $95,140 | 3 |
May 31, 2024
Added 29.8%
|
|
| 11,286 | 0 | 11,286 $95,140 | 3 |
May 31, 2024
Added 29.8%
|
|
| 11,286 | 0 | 11,286 $95,140 | 3 |
May 31, 2024
Added 29.8%
|
|
| 11,286 | 0 | 11,286 $95,140 | 3 |
May 31, 2024
Added 29.8%
|